Molecular pharmacology of glutamate transporters, EAATs and VGLUTs

Brain Research Reviews

Volumn 45, Issue 3, 2004, Pages 250-265

  Shigeri, Yasushi ^a   Seal, Rebecca P ^b   Shimamoto, Keiko ^c  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

EAATs; Excitatory neurotransmitter; Glutamate; Glutamate transporter; Neurotransmitters, modulators, transporters and receptors; Uptake and transporters; VGLUTs

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKALOID DERIVATIVE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID; AMINO ACID DERIVATIVE; ASPARTIC ACID; ASPARTIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; DYE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; KAINIC ACID DERIVATIVE; METHYLGLUTAMATE; SERINE DERIVATIVE; SODIUM DEPENDENT GLUTAMATE TRANSPORTER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DEMENTIA; ENZYME ACTIVITY; EPILEPSY; GLIOBLASTOMA; HUMAN; HUNTINGTON CHOREA; IC 50; MENTAL DISEASE; MOLECULAR CLONING; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SCHIZOPHRENIA; SYNAPSE VESICLE; ULTRAVIOLET IRRADIATION;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANIMALS; CARRIER PROTEINS; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMIC ACID; HUMANS; LIGANDS; MEMBRANE TRANSPORT PROTEINS; MODELS, NEUROLOGICAL; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NEUROGLIA; NEURONS; STRUCTURE-ACTIVITY RELATIONSHIP; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR TRANSPORT PROTEINS;

EID: 3042556105     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2004.04.004     Document Type: Review

References (127)

1. Arriza J.L., Kavanaugh M.P., Fairman W.A., Wu Y.N., Murdoch G.H., North R.A., Amara S.G. Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J. Biol. Chem. 268:1993;15329-15332
2. Arriza J.L., Fairman W.A., Wadiche J., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from motor cortex. J. Neurosci. 14:1994;5559-5569
3. Arriza J.L., Eliasof S., Kavanaugh M.P., Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4155-4160
4. Bak L.K., Schousboe A., Waagepetersen H.S. Characterization of depolarization-coupled release of glutamate from cultured mouse cerebellar granule cells using DL-threo-beta-benzyloxyaspartate (DL-TBOA) to distinguish between the vesicular and cytoplasmic pools. Neurochem. Int. 43:2003;417-424
5. Baker D.A., Xi Z., Shen H., Swanson C.J., Kalivas P.W. The origin and neuronal function of in vivo nonsynaptic glutamate. J. Neurosci. 22:2002;9134-9141
6. +-dependent transport of acidic amino acids in the mammalian central nervous system. Biol. Pharm. Bull. 25:2002;291-301
7. Balcar V.J., Li Y. Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci. 51:1992;1467-1478
8. Bartlett R.D., Esslinger C.S., Thompson C.M., Bridges R.J. Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles. Neuropharmacology. 37:1998;839-846
9. Béliveau R., Demeule M., Jetté M., Potier M. Molecular sizes of amino acid transporters in the luminal membrane from the kidney cortex, estimated by the radiation-inactivation method. Biochem. J. 268:1990;195-220
10. Bellocchio E.E., Reimer R.J., Fremeau R.T., Edwards R.H. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science. 289:2000;957-960
11. Bergles D.E., Diamond J.S., Jahr C.E. Clearance of glutamate inside the synapse and beyond. Curr. Opin. Neurobiol. 9:1999;293-298
12. Bergles D.E., Tzingounis A.V., Jahr C.E. Comparison of coupled and uncoupled currents during glutamate uptake by GLT-1 transporters. J. Neurosci. 22:2002;10153-10162
13. Bezzi P., Domercq M., Vesce S., Volterra A. Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Prog. Brain Res. 132:2001;255-265
14. Blitzblau R., Gupta S., Djali S., Robinson M.B., Rosenberg P.A. The glutamate transport inhibitor L-trans-pyrrolidine-2, 4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures. Eur. J. Neurosci. 8:1996;1840-1852
15. Borre L., Kanner B.I. Coupled, but not uncoupled, fluxes in a neuronal glutamate transporter can be activated by lithium ions. J. Biol. Chem. 276:2001;40396-40401
16. Borre L., Kavanaugh M.P., Kanner B.I. Dynamic equilibrium between coupled and uncoupled modes of a neuronal glutamate transporter. J. Biol. Chem. 277:2002;13501-13507
17. Brasnjo G., Otis T.S. Neuronal glutamate transporters control activation of postsynaptic metabotropic glutamate receptors and influence cerebellar long-term depression. Neuron. 31:2001;607-616
18. Brauner-Osborne H., Hermit M.B., Nielsen B., Krogsgaard-Larsen P., Johansen T.N. A new structural class of subtype-selective inhibitor of cloned excitatory amino acid transporter, EAAT2. Eur. J. Pharmacol. 406:2000;41-44
19. Bridges R.J., Stanley M.S., Anderson M.W., Cotman C.W., Chamberlin A.R. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2, 4-dicarboxylate diastereomers. J. Med. Chem. 34:1991;717-725
20. Bridges R.J., Lovering F.E., Koch H., Cotman C.W., Chamberlin A.R. A conformationally constrained competitive inhibitor of the sodium-dependent glutamate transporter in forebrain synaptosomes: L-anti-endo-3, 4-methanopyrrolidine dicarboxylate. Neurosci. Lett. 174:1994;193-197
21. Bridges R.J., Kavanaugh M.P., Chamberlin A.R. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Curr. Pharm. Des. 5:1999;363-379
22. Campiani G., De Angelis M., Armaroli S., Fattorusso C., Catalanotti B., Ramunno A., Nacci V., Novellino E., Grewer C., Ionescu D., Rauen T., Griffiths R., Sinclair C., Fumagalli E., Mennini T. A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3), new glutamate and aspartate analogues as potential neuroprotective agents. J. Med. Chem. 44:2001;2507-2510
23. Campiani G., Fattorusso C., De Angelis M., Catalanotti B., Butini S., Fattorusso R., Fiorini I., Nacci V., Novellino E. Neuronal high-affinity sodium-dependent glutamate transporters (EAATs): targets for the development of novel therapeutics against neurodegenerative diseases. Curr. Pharm. Des. 9:2003;599-625
24. Carlson M.D., Kish P.E., Ueda T. Glutamate uptake into synaptic vesicles: competitive inhibition by bromocriptine. J. Neurochem. 53:1989;1889-1894
25. Carrigan C.N., Esslinger C.S., Bartlett R.D., Bridges R.J., Thompson C.M. Quinoline-2, 4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system. Bioorg. Med. Chem. Lett. 9:1999;2607-2612
26. Carrigan C.N., Bartlett R.D., Esslinger C.S., Cybulski K.A., Tongcharoensirikul P., Bridges R.J., Thompson C.M. Synthesis and in vitro pharmacology of substituted quinoline-2, 4-dicarboxylic acids as inhibitors of vesicular glutamate transport. J. Med. Chem. 45:2002;2260-2276
27. Clausen R.P., Brauner-Osborne H., Greenwood J.R., Hermit M.B., Stensbol T.B., Nielsen B., Krogsgaard-Larsen P. Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1, 2, 5]thiadiazol-3-yl) butyric acid. J. Med. Chem. 45:2002;4240-4245
28. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65:2001;1-105
29. Diamond J.S. Neuronal glutamate transporters limit activation of NMDA receptors by neurotransmitter spillover on CA1 pyramidal cells. J. Neurosci. 21:2001;8328-8338
30. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51:1999;7-61
31. 2.6]heptane- 1, 3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake. Br. J. Pharmacol. 140:2003;839-846
32. Eliasof S., McIlvain H.B., Petroski R.E., Foster A.C., Dunlop J. Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systems. J. Neurochem. 77:2001;550-557
33. Eskandari S., Kreman M., Kavanaugh M.P., Wright E.M., Zampighi G.A. Pentameric assembly of a neuronal glutamate transporter. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8641-8646
34. Esslinger C.S., Koch H.P., Kavanaugh M.P., Philips D.P., Chamberlin A.R., Thompson C.M., Bridges R.J. Structural determinants of substrates and inhibitors: probing glutamate transporters with 2, 4-methanopyrrolidine-2, 4-dicarboxylate. Bioorg. Med. Chem. Lett. 8:1998;3101-3106
35. Esslinger C.S., Titus J., Koch H., Bridges R.J., Chamberlin A.R. Methylation of L-trans-2, 4-pyrrolidine dicarboxylate converts the glutamate transport inhibitor from a substrate to a non-substrate inhibitor. Bioorg. Med. Chem. 10:2002;3509-3515
36. Fairman W.A., Vandenberg R.J., Arriza J.L., Kavanaugh M.P., Amara S.G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature. 375:1995;599-603
37. Fairman W.A., Sonders M.S., Murdoch G.H., Amara S.G. Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4. Nat. Neurosci. 1:1998;105-113
38. Ferkany J., Coyle J.T. Heterogeneity of sodium-dependent excitatory amino acid uptake mechanisms in rat brain. J. Neurosci. Res. 16:1986;491-503
39. Fletcher E.J., Johnston G.A. Regional heterogeneity of L-glutamate and L-aspartate high-affinity uptake systems in the rat CNS. J. Neurochem. 57:1991;911-914
40. Fletcher E.J., Mewett K.N., Drew C.A., Allan R.D., Johnston G.A. Inhibition of high affinity L-glutamic acid uptake into rat cortical synaptosomes by the conformationally restricted analogue of glutamic acid, cis-1-aminocyclobutane-1, 3-dicarboxylic acid. Neurosci. Lett. 121:1991;133-135
41. Fremeau R.T., Troyer M.D., Pahner I., Nygaard G.O., Tran C.H., Reimer R.J., Bellocchio E.E., Fortin D., Storm-Mathisen J., Edwards R.H. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron. 31:2001;247-260
42. Fremeau R.T., Burman J., Qureshi T., Tran C.H., Proctor J., Johnson J., Zhang H., Sulzer D., Copenhagen D.R., Storm-Mathisen J., Reimer R.J., Chaudhry F.A., Edwards R.H. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc. Natl. Acad. Sci. U. S. A. 99:2002;14488-14493
43. Goodman S.R., Zimmer W.E., Clark M.B., Barker I.S., Bloom M.L. Brain spectrin: of mice and men. Brain Res. Bull. 36:1995;593-606
44. Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., Gasnier B., Giros B., El Mestikawy S. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J. Neurosci. 22:2002;5442-5451
45. Griffiths R., Dunlop J., Gorman A., Senior J., Grieve A. L-trans-pyrrolidine-2, 4-dicarboxylate and cis-1-aminocyclobutane-1, 3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters. Biochem. Pharmacol. 47:1994;267-274
46. Grunewald M., Bendahan A., Kanner B.I. Biotinylation of single cysteine mutants of the glutamate transporter GLT-1 from rat brain reveals its unusual topology. Neuron. 21:1998;623-632
47. Grunewald M., Menaker D., Kanner B.I. Cysteine-scanning mutagenesis reveals a conformationally sensitive reentrant pore-loop in the glutamate transporter GLT-1. J. Biol. Chem. 277:2002;26074-26080
48. Hamberger A.C., Chiang G.H., Nylen E.S., Scheff S.W., Cotman C.W. Glutamate as a CNS transmitter: I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate. Brain Res. 168:1979;513-530
49. Haskew R.E., Mongin A.A., Kimelberg H.K. Peroxynitrite enhances astrocytic volume-sensitive excitatory amino acid release via a src tyrosine kinase-dependent mechanism. J. Neurochem. 82:2002;903-912
50. Haugeto O., Ullensvang K., Levy L.M., Chaudhry F.A., Honore T., Nielsen M., Lehre K.P., Danbolt N.C. Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271:1996;27715-27722
51. Herzog E., Bellenchi G.C., Gras C., Bernard V., Ravassard P., Bedet C., Gasnier B., Giros B., El Mestikawy S. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J. Neurosci. 21:2001;1-6. (RC181)
52. Hollmann M., Heinemann S.F. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108
53. Ikemoto M.J., Inoue K., Akiduki S., Osugi T., Imamura T., Ishida N., Ohtomi M. Identification of addicsin/GTRAP3-18 as a chronic morphine-augmented gene in amygdala. NeuroReport. 13:2002;2079-2084
54. Ikemoto A., Bole D.G., Ueda T. Glycolysis and glutamate accumulation into synaptic vesicles. J. Biol. Chem. 278:2003;5929-5940
55. Jabaudon D., Shimamoto K., Yasuda-Kamatani Y., Scanziani M., Gahwiler B.H., Gerber U. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8733-8738
56. Jackson M., Song W., Liu M.Y., Jin L., Dykes-Hoberg M., Lin C.I., Bowers W.J., Federoff H.J., Sternweis P.C., Rothstein J.D. Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature. 410:2001;89-93
57. Johansen T.N., Janin Y.L., Nielsen B., Frydenvang K., Brauner-Osborne H., Stensbol T.B., Vogensen S.B., Madsen U., Krogsgaard-Larsen P. 2-Amino-3-(3-hydroxy-1, 2, 5-thiadiazol-4-yl)propionic acid: resolution, absolute stereochemistry and enantiopharmacology at glutamate receptors. Bioorg. Med. Chem. 10:2002;2259-2266
58. Kalandadze A., Wu Y., Robinson M.B. Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J. Biol. Chem. 277:2002;45741-45750
59. Kanai Y., Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 360:1992;467-471
60. Kanai Y., Nussberger S., Romero M.F., Boron W.F., Hebert S.C., Hediger M.A. Electrogenic properties of the epithelial and neuronal high affinity glutamate transporter. J. Biol. Chem. 270:1995;16561-16568
61. Kaneko T., Fujiyama F., Hioki H. Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain. J. Comp. Neurol. 444:2002;39-62
62. Kanner B.I., Borre L. The dual-function glutamate transporters: structure and molecular characterisation of the substrate-binding sites. Biochim. Biophys. Acta. 1555:2002;92-95
63. Kanner B.I., Kavanaugh M.P., Bendahan A. Molecular characterization of substrate-binding sites in the glutamate transporter family. Biochem. Soc. Trans. 6:2001;707-710
64. 2+ increase. Eur. J. Pharmacol. 211:1992;195-202
65. Kawazura H., Takahashi Y., Shiga Y., Shimada F., Ohto N., Tamura A. Cerebroprotective effects of a novel pyrazoline derivative, MS-153, on focal ischemia in rats. Jpn. J. Pharmacol. 73:1997;317-324
66. Koch H.P., Kavanaugh M.P., Esslinger C.S., Zerangue N., Humphrey J.M., Amara S.G., Chamberlin A.R., Bridges R.J. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol. Pharmacol. 6:1999;1095-1104
67. Koch H.P., Chamberlin A.R., Bridges R.J. Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult. Mol. Pharmacol. 55:1999;1044-1048
68. Lebrun B., Sakaitani M., Shimamoto K., Yasuda-Kamatani Y., Nakajima T. New beta-hydroxyaspartate derivatives are competitive blockers for the bovine glutamate/aspartate transporter. J. Biol. Chem. 272:1997;20336-20339
69. Leighton B.H., Seal R.P., Shimamoto K., Amara S.G. A hydrophobic domain in glutamate transporters forms an extracellular helix associated with the permeation pathway for substrates. J. Biol. Chem. 277:2002;29847-29855
70. Levy L.M., Warr O., Attwell D. Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 18:1998;9620-9628
71. Li J.L., Fujiyama F., Kaneko T., Mizuno N. Expression of vesicular glutamate transporters, VGluT1 and VGluT2, in axon terminals of nociceptive primary afferent fibers in the superficial layers of the medullary and spinal dorsal horns of the rat. J. Comp. Neurol. 457:2003;236-249
72. Lin C.I., Orlov I., Ruggiero A.M., Dykes-Hoberg M., Lee A., Jackson M., Rothstein J.D. Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature. 410:2001;84-88
73. +-glutamate cotransporter expressed in Xenopus oocytes. J. Physiol. 542.3:2002;817-828
74. Martin S.J., O'Brien G.A., Nishioka W.K., McGahon A.J., Mahboubi A., Saido T.C., Green D.R. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270:1995;6425-6428
75. Mathews G.C., Diamond J.S. Neuronal glutamate uptake contributes to GABA synthesis and inhibitory synaptic strength. J. Neurosci. 23:2003;2040-2048
76. Moriyama Y., Amakatsu K., Yamada H., Park M.Y., Futai M. Inhibition of neurotransmitter and hormone transport into secretory vesicles by 2-(4-phenylpiperidino)cyclohexanol and 2-bromo-alpha-ergocryptine: both compounds act as uncouplers and dissipate the electrochemical gradient of protons. Arch. Biochem. Biophys. 290:1991;233-238
77. Munch C., Ebstein M., Seefried U., Zhu B., Stamm S., Landwehrmeyer G.B., Ludolph A.C., Schwalenstocker B., Meyer T. Alternative splicing of the 5′-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J. Neurochem. 82:2002;594-603
78. Nakamura Y., Kataoka K., Ishida M., Shinozaki H. (2S, 3S, 4R)-2-(carboxycyclopropyl)glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate. Neuropharmacology. 32:1993;833-837
79. Ogita K., Hirata K., Bole D.G., Yoshida S., Tamura Y., Leckenby A.M., Ueda T. Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal. J. Neurochem. 77:2001;34-42
80. O'Shea R.D., Fodera M.V., Aprico K., Dehnes Y., Danbolt N.C., Crawford D., Beart P.M. Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity. Neurochem. Res. 27:2002;5-13
81. Ozawa S., Kamiya H., Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54:1998;581-618
82. Ozkan E.D., Ueda T. Glutamate transport and storage in synaptic vesicles. Jpn. J. Pharmacol. 77:1998;1-10
83. Ozkan E.D., Lee F.S., Ueda T. A protein factor that inhibits ATP-dependent glutamate and gamma-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4137-4142
84. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain L-glutamate transporter. Nature. 360:1992;464-467
85. Reimer R.J., Fremeau R.T., Bellocchio E.E., Edwards R.H. The essence of excitation. Curr. Opin. Cell Biol. 13:2001;417-421
86. Robinson M.B. Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 80:2002;1-11
87. 3H]glutamate transport processes in rat brain. Brain Res. 544:1991;196-202
88. Roseth S., Fykse E.M., Fonnum F. Uptake of L-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J. Neurochem. 65:1995;96-103
89. Ryan R.M., Vandenberg R.J. Distinct conformational states mediate the transport and anion channel properties of the glutamate transporter EAAT-1. J. Biol. Chem. 277:2002;13494-13500
90. Schafer M.K., Varoqui H., Defamie N., Weihe E., Erickson J.D. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J. Biol. Chem. 277:2002;50734-50748
91. Seal R.P., Amara S.G. A reentrant loop domain in the glutamate carrier EAAT1 participates in substrate binding and translocation. Neuron. 21:1998;1487-1498
92. Seal R.P., Amara S.G. Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39:1999;431-456
93. Seal R.P., Leighton B.H., Amara S.G. A model for the topology of excitatory amino acid transporters determined by the extracellular accessibility of substituted cysteines. Neuron. 25:2000;695-706
94. Seal R.P., Shigeri Y., Eliasof S., Leighton B.H., Amara S.G. Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductance. Proc. Natl. Acad. Sci. U. S. A. 98:2001;15324-15329
95. +/glutamate cotransporters. J. Biol. Chem. 268:1993;15351-15355
96. Shigeri Y., Shimamoto K., Yasuda-Kamatani Y., Seal R.P., Yumoto N., Nakajima T., Amara S.G. Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5). J. Neurochem. 79:2001;297-302
97. Shimada F., Shiga Y., Morikawa M., Kawazura H., Morikawa O., Matsuoka T., Nishizaki T., Saito N. The neuroprotective agent MS-153 stimulates glutamate uptake. Eur. J. Pharmacol. 386:1999;263-270
98. Shimamoto K., Ohfune Y. Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors. J. Med. Chem. 39:1996;407-423
99. Shimamoto K., Ishida M., Shinozaki H., Ohfune Y. Synthesis of four diastereomeric L-2-(carboxycyclopropyl)glycines. Conformationally constrained L-glutamate analogues. J. Org. Chem. 56:1991;4167-4176
100. Shimamoto K., Lebrun B., Yasuda-Kamatani Y., Sakaitani M., Shigeri Y., Yumoto N., Nakajima T. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol. Pharmacol. 53:1998;195-201
101. Shimamoto K., Shigeri Y., Yasuda-Kamatani Y., Lebrun B., Yumoto N., Nakajima T. Syntheses of optically pure β-hydroxyaspartate derivatives as glutamate transporter blockers. Bioorg. Med. Chem. Lett. 10:2000;2407-2410
102. Shimamoto K., Sakai R., Takaoka K., Yumoto N., Nakajima T., Amara S.G., Shigeri Y. Characterization of novel L-threo-β-benzyloxyaspartate derivatives, high affinity blockers for the glutamate transporters. Mol. Pharmacol. 65:2004;1008-1015
103. Shinozaki H., Ishida M., Shimamoto K., Ohfune Y. Potent NMDA-like action and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord. Br. J. Pharmacol. 98:1989;1213-1224
104. Siman R., Baudry M., Lynch G. Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature. 313:1985;225-228
105. Sims K.D., Straff D.J., Robinson M.B. Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275:2000;5228-5237
106. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10955-10959
107. Su Z., Leszczyniecka M., Kang D., Sarkar D., Chao W., Volsky D.J., Fisher P.B. Insights into glutamate transport regulation in human astrocytes: cloning of the promotor for excitatory amino acid transporter2 (EAAT2). Proc. Natl. Acad. Sci. U. S. A. 100:2003;1955-1960
108. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature. 407:2000;189-194
109. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J. Neurosci. 21:2001;1-6. (RC182)
110. Takamori S., Malherbe P., Broger C., Jahn R. Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Rep. 3:2002;798-803
111. Takaoka K., Tatsu Y., Yumoto N., Nakajima T., Shimamoto K. Synthesis and photoreactivity of caged blockers for glutamate transporters. Bioorg. Med. Chem. Lett. 13:2003;965-970
112. 2+-dependent, evoked release of glutamate, GABA and serotonin. J. Neurochem. 76:2001;1153-1164
113. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science. 276:1997;1699-1702
114. 14C]glutamine. J. Neurochem. 41:1983;611-617
115. Tzingounis A.V., Lin C.L., Rothstein J.D., Kavanaugh M.P. Arachidonic acid activates a proton current in the rat glutamate transporter EAAT4. J. Biol. Chem. 273:1998;17315-17317
116. Umemura K., Gemba T., Mizuno A., Nakashima M. Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion. Stroke. 27:1996;1624-1628
117. +-dependent neutral amino acid transporter. J. Biol. Chem. 271:1996;14883-14890
118. Vandenberg R.J., Mitrovic A.D., Chebib M., Balcar V.J., Johnston G.A. Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol. Pharmacol. 51:1997;809-815
119. Vandenberg R.J., Mitrovic A.D., Johnston G.A. Serine-O-sulphate transport by the human glutamate transporter, EAAT2. Br. J. Pharmacol. 123:1998;1593-1600
120. +/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J. Neurosci. 22:2002;142-155
121. Wadich J.I., Kavanaugh M.P. Macroscopic and microscopic properties of a cloned glutamate transporter/chloride channel. J. Neurosci. 18:1998;7650-7661
122. Wadich J.I., Arriza J.L., Amara S.G., Kavanaugh M.P. Kinetics of a human glutamate transporter. Neuron. 14:1995;1019-1027
123. Wadiche J.I., Amara S.G., Kavanaugh M.P. Ion fluxes associated with excitatory amino acid transport. Neuron. 15:1995;721-728
124. Willis C.L., Humphrey J.M., Koch H.P., Hart J.A., Blakely T., Ralston L., Baker C.A., Shim S., Kadri M., Chamberlin A.R., Bridges R.J. L-trans-2, 3-pyrrolidine dicarboxylate: characterization of a novel excitotoxin. Neuropharmacology. 35:1996;531-539
125. Winter H.C., Ueda T. Glutamate uptake system in the presynaptic vesicle: glutamic acid analogs as inhibitors and alternate substrates. Neurochem. Res. 1:1993;79-85
126. Zerangue N., Kavanaugh M.P. Flux coupling in a neuronal glutamate transporter. Nature. 383:1996;634-637
127. Zhou L.M., Gu Z.Q., Costa A.M., Yamada K.A., Mansson P.E., Giordano T., Skolinick P., Jones K.A. (2S, 4R)-4-Methylglutamic acid (SYM2081): a selective, high-affinity ligand for kainate receptors. J. Pharmacol. Exp. Ther. 280:1997;422-427